Evaluation of Brainstem Auditory Evoked Potential in Essential Hypertension by Priya, V
1A  Dissertation on
EVALUATION OF BRAINSTEM AUDITORY EVOKED
POTENTIAL IN  ESSENTIAL HYPERTENSION
Submitted to
The Tamil Nadu Dr.M.G.R. Medical University,
In partial fulfilment of the requirements for
the award of Degree of
DOCTOR OF MEDICINE
Branch - V : M.D. (Physiology)
THE TAMIL NADU DR.M.G.R. MEDICAL UNIVERSITY
CHENNAI – 600 032, INDIA
APRIL 2015
2CERTIFICATE
This is to certify that “EVALUATION OF BRAINSTEM
AUDITORY EVOKED POTENTIAL IN ESSENTIAL
HYPERTENSION’’ is bonafide work done by the Post Graduate
Dr.PRIYA .V, Department of  Physiology, Kilpauk Medical College,
Chennai – 10  under my guidance and supervision in partialfulfilment of
regulations of The  Tamilnadu Dr.M.G.R.Medical University for the
award  of  M.D  (PHYSIOLOGY)  BRANCH  –  V   during  the  academic
period from 2012 – 2015.
Prof.Dr.N.Gunasekaran, M.D., D.T.C.D., Prof.Dr.A.Rasheeda, M.D.,
Dean Head of Department
Kilpauk Medical College, Physiology,
Chennai-10. Kilpauk Medical College,
Chennai – 10.
3DECLARATION
I, DR.V.PRIYA, solemnly declare that dissertation titled
“EVALUATION OF BRAINSTEM AUDITORY EVOKED
POTENTIAL IN ESSENTIAL HYPERTENSION” is a bonafide work
done by me at Institute of Physiology,Kilpauk Medical College and
Hospital from August 2013 to July 2014 under the guidance and
supervision of Prof.Dr.A.RASHEEDA, M.D., Professor of Physiology.
This dissertation is submitted to The Tamilnadu Dr.M.G.R.Medical
University ,towards partial fulfilement of requirement for the award of
M.D.Degree ( Branch – V) in Physiology.
Place : Chennai.
Date : (Dr.V.PRIYA)
4ACKNOWLEDGEMENT
I sincerely thank Prof.Dr.N.Gunasekeran, M.D., D.T.C.D., Dean,
Kilpauk Medical College, Chennai for permitting me to utilize the
facilities needed for this dissertation work.
I am extremely grateful to my Prof.Dr.A.RASHEEDA ,M.D.,
Professor and Head of the Department of Physiology, Kilpauk Medical
College and Hospital for permitting me to carry out this study and for her
constant encouragement and guidance.
I owe my sincere gratitude to my Prof.Rajaseharan, M.D.,
Professor, Department of Physiology ,Kilpauk Medical College for his
esteemed guidance and valuable suggestions in all the stages of this
dissertation.
I also express my sincere gratitude to Prof.A.Shakeela Banu,
M.D., Prof.LillyPushpam, M.D., for their help and guidance rendered
during the entire period of my work.
I whole heartedly express my sincere thanks to Prof.Gunasekaran
M.D., Head of Department of Medicine, Kilpauk Medical College,
Chennai for his valuable guidance and support throughout my dissertation
work.
I  wish  to   thank Dr.K.R.SenthilKumari, M.D., Dr.Shanthini,
M.D., Dr.M.Anitha, M.D., Dr.B.Anitha, Dr.Chandra, M.D.,
Dr.M.Shivaraj, M.D., Assistants Professors, Department of Physiology,
Kilpauk Medical College for their valuable suggestions and help rendered
throughout this work.
5I  also  wish  to  thank Dr.Jaganathan,  M.D.,  Department  of
Pathology, Kilpauk Medical College, Chennai for his valuable guidance
in statistical work throughout my  dissertation work.
I also thank my Husband, Kid, Parents, Colleagues, Friends and
Staff of our hospital, for their support of this work.
Last but not the least, with sincere gratitude, I thank all the patients
who contributed so much to this study without whom this  study could
not have been possible.
6CONTENTS
Sl. No. Title Page No
1. INTRODUCTION 1
2. REVIEW OF LITERATURE 34
3. AIM AND OBJECTIVE OF THE STUDY 45
4. MATERIALS AND METHODS 46
5. RESULTS 71
6. DISCUSSION 73
7. CONCLUSION 75
BIBLIOGRAPHY
ANNEXURES
MASTER SHEET
7LIST OF TABLES
S.No DETAILS
1. Classification of Hypertension
2. Anthropometric Measurements of Hypertensive
Subjects with Controls
3. Comparison of Blood Pressure in Hypertension and
Control
4. Frequency Distribution of Hypertension in Stage I –
IV
5. Comparison of Absolute Peak Latencies between
Hypertension and Control of Right Ear
6. Comparison of Inter Peak Latencies between
Hypertension and Control of Right Ear
7. Comparison of  Absolute Peak Latencies between
Hypertension and Control of Left Ear
8. Comparison of Inter Peak Latencies between Case
and Control of Left Ear
8LIST OF FIGURES
S.NO FIGURE
1. Schematic Diagram of Anatomy of Ear
2. Schematic Diagram of Inner Ear
3. Schematic Diagram of Organ of corti
4. Schematic Diagram of Auditory Pathway
5. Schematic Diagram of Waveforms
6. Comparison of Anthropometric Measurements of
Hypertensives and Controls
7. Comparison of Blood Pressure in Hypertensive subjects
and Controls
8. Comparison of  Absolute Peak Latencies between
Hypertension and Controls of Right Ear
9. Comparison of Inter Peak Latencies between
Hypertension and Controls of Right Ear
10. Comparison of Absolute Peak Latencies between
Hypertension and Controls of Left Ear
11. Comparison of Inter Peak Latencies between
Hypertension and Controls of Left Ear
9LIST OF ABBREVIATIONS
BAEP – Brainstem Auditory Evoked Potentials
HT – Hypertension
CHD –  Coronary Heart Disease
ABR – Auditory Brainstem Response
MRFIT   – Multiple Risk Factor Intervention Trial
PRA – Plasma Renin Activity
PIH – Pregnancy Induced Hypertension
mA –  milli – Amperes
mV – millivolts
?? - milli – ohms
ms – milliseconds
µS – microseconds
ADC – Analogue to Digital Converter
IPL –  Inter Peak Latencies
Ai – Ipsilateral Ear
AC – Contralateral Ear
CRO – Cathode Ray Oscilloscope
APL - Absolute Peak Latency
ABSTRACT
Central nervous system dysfunctions are common in patients of essential
hypertension.Arterial and  arteriolar spasm  in cerebral  blood  vessels may be
responsible.Micro-infarctions are known to be responsible for dysfunction in
heart,kidney ,brain and other tissues in patients of hypertension.Brainstem
auditory evoked potentials are the potentials recorded from the ear &vertex  in
response to a brief auditory stimulation to assess the conduction through
auditory pathway upto midbrain.
This study will be executed to evaluate subclinical brainstem auditory
evoked potentials abnormalities  in essential hypertension.
? STUDY DESIGN :
-Case control study.
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INTRODUCTION
Blood pressure  is the lateral  pressure  exerted by the flowing
blood on the walls of the vessels5.It is usually  measured  in mmHg.
Without any further qualification the term blood pressure denotes arterial
pressure. While describing the pressure exerted   by the blood column in
other types of blood vessels, the type of  vessels is also  mentioned , e.g.
capillary pressure and venous pressure.
Very   few diseases are responsible for frequent and severe
complications due to Arterial Hypertension8. Insufficiency of blood flow
to Heart, Kidney and peripheral blood vessels is common in arterial
hypertension10, 11. Moreover, it is estimated that about half of the deaths
of patients above 50 years are due to cardiovascular diseases, and 80% of
them have high blood pressure. Human body depends on proper supply of
oxygen and nutrients 10 in order to maintain their function and such
supply depends on functional and structural integrity of heart and blood
vessels. High pressure in vascular system may cause haemorrhage in
inner ear supplied by anterior inferior cerebellar artery14 .This artery
supports the inner ear, cochlear artery and anterior vestibular artery which
may cause progressive or sudden hearing loss.8
  Hypertension is an accelerating factor for degeneration  of hearing
apparatus55.In patients with Primary Hypertension ,Central nervous
system dysfunctions occurs frequently1.Systemic arterial hypertension is
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an independent risk factor for hearing loss 8.Regulation of blood pressure
at the brainstem level is affected in Essential Hypertension. Arterial and
arteriolar spasm along with fibrinoid degeneration leads to
microinfarction and cerebral edema in severe cases of hypertension30.
Hence ,the sensory deficit could be due to either the cause i.e primary
disorder of sympathetic system responsible for essential hypertension or
due to it’s effects.22
   As per Bernoulli’s experiment ,the lateral pressure  exerted  on
the vessel by the flowing blood represents the potential energy and the
end  on  pressure  represents  the  total  energy,   i.e  kinetic  energy   plus
potential energy5.Kinetic energy depends on the velocity of blood flow.
Therefore, velocity of flowing blood remaining constant, a rise in lateral
pressure indicates a rise in perfusion pressure and vice versa.5
HYPERTENSION
Definition: Hypertension (HT) refers to a condition in which value
of systolic blood pressure is persistently more than 140mmHg and /or that
of  diastolic blood pressure is above 90mmHg5 .If there is increase only in
systolic blood pressure ,it is called systolic hypertension in which pulse
pressure  is  raised.  In  adults  there  is  a  continuous,  incremental  risk  of
cardiovascular disease, stroke, and renal disease across levels of both
systolic and diastolic blood pressure. The Multiple Risk Factor
Intervention Trial (MRFIT), which included >350,000 male participants,
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demonstrated a continuous and graded influence of both systolic and
diastolic blood pressure on CHD mortality, extending down to systolic
blood pressures of 120 mmHg. Similarly, results of a meta-analysis
involving almost 1 million participants indicate that ischemic heart
disease mortality, stroke mortality, and mortality from other vascular
causes are directly related to the height of the blood pressure, beginning
at 114/76 mmHg, without evidence of a threshold. Cardiovascular disease
risk doubles for every 20-mmHg increase in systolic and 10-mmHg
increase in diastolic pressure4. Among older individuals, systolic blood
pressure and pulse pressure are more powerful predictors of
cardiovascular disease than diastolic blood pressure.
Clinically, hypertension might be defined as that level of blood
pressure at which the institution of therapy reduces blood pressure–
related morbidity and mortality. Current clinical criteria for defining
hypertension are generally based on the average of two or more seated
blood pressure readings during each of two or more outpatient visits. A
recent classification recommends blood pressure criteria for defining
normal blood pressure, prehypertension, hypertension (stages I and II),
and isolated systolic hypertension, which is a common occurrence among
the elderly4. In children and adolescents, hypertension is generally
defined as systolic and/or diastolic blood pressure consistently >95th
percentile for age, gender, and height.
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Blood Pressure Classification
Blood Pressure Classification Systolic, mmHg Diastolic, mmHg
Normal <120 and<80
Prehypertension 120–139 or 80–89
Stage 1 hypertension 140–159 or 90–99
Stage 2 hypertension
160 or 100
Isolated systolic hypertension
140
and<90
Home blood pressure and average 24-h ambulatory blood pressure
measurements are generally lower than clinic blood pressures. Because
ambulatory blood pressure4 recordings yield multiple readings throughout
the day and night, they provide a more comprehensive assessment of the
vascular burden of hypertension than a limited number of office readings.
Increasing evidence suggests that home blood pressures, including 24-h
blood pressure recordings, more reliably predict target organ damage than
office blood pressures. Blood pressure tends to be higher in the early
morning hours, soon after waking, than at other times of day. Myocardial
infarction and stroke are more frequent in the early morning hours.
Nighttime blood pressures are generally 10–20% lower than daytime
blood pressures, and an attenuated nighttime blood pressure "dip" is
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associated with increased cardiovascular disease risk. Blunting of the
day-night blood pressure pattern occurs in several clinical conditions,
including sleep apnea and autonomic neuropathy, and in certain
populations, including African Americans4. Recommended criteria for a
diagnosis of hypertension are average awake blood pressure 134/86
mmHg and asleep blood pressure 120/76 mmHg. These levels
approximate a clinic blood pressure of 140/90 mmHg.4
Approximately 15–20% of patients with stage 1 hypertension
based on blood pressures have average ambulatory readings <134/86
mmHg. This phenomenon, so-called white coat hypertension, may also be
associated with an increased risk of target organ damage (e.g., left
ventricular hypertrophy, carotid atherosclerosis, overall cardiovascular
morbidity), although to a lesser extent than individuals with elevated
office and ambulatory readings. Individuals with white coat hypertension
are also at increased risk for developing sustained hypertension.
Types of hypertension: It is of two types
1. Primary  hypertension
2. Secondary hypertension
Essential Hypertension
Essential hypertension tends to be familial and is likely to be the
consequence of an interaction between environmental and genetic factors.
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The prevalence of essential hypertension increases with age, and
individuals with relatively high blood pressures at younger ages are at
increased risk4 for the subsequent development of hypertension. It is
likely that essential hypertension represents a spectrum of disorders with
different underlying pathophysiologies. In the majority of patients with
established hypertension, peripheral resistance is increased and cardiac
output is normal or decreased; however, in younger patients with mild or
labile hypertension, cardiac output may be increased and peripheral
resistance may be normal.
When plasma renin activity (PRA) is plotted against 24-h sodium
excretion, ~10–15% of hypertensive patients have high PRA and 25%
have low PRA4. High-renin patients may have a vasoconstrictor form of
hypertension, whereas low-renin patients may have a volume-dependent
hypertension. Inconsistent associations between plasma aldosterone and
blood pressure have been described in patients with essential
hypertension. The association between aldosterone and blood pressure is
more striking in African Americans, and PRA tends to be low in
hypertensive African Americans. This raises the possibility that subtle
increases of aldosterone may contribute to hypertension in at least some
groups of patients who do not have overt primary aldosteronism.
Furthermore, spironolactone, an aldosterone antagonist, may be a
particularly effective antihypertensive agent for some patients with
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essential hypertension, including some patients with "drug-resistant"
hypertension.
Secondary hypertension   refers to a condition  in which blood
pressure is raised due to some other underlying disease.Common causes
of secondary hypertension are:
Cardio vascular diseases producing secondary hypertension are
atherosclerosis  and  coarctation of aorta4 .
Renal diseases causing secondary  hypertension  are stenosis of
renal artery, glomerulonephritis and tumour of juxtaglomerular cells
leading to formation of excess of  angiotension II.
Endocrinal disorders  associated with secondary hypertension  are
hyperaldosteronism, pheochromocytoma and cushing’s  syndrome .
Neurological disorders which may produce secondary hypertension
include raised intra cranial pressure, tractussolitarious  and sectioning of
nerve fibres from  carotid  sinus.
Pregnancy –induced hypertension (PIH) is  noticed in some of the
pregnant women. Its exact cause is not known. It may be because of some
autoimmune processes during pregnancy or the release of some
vasoconstrictor agents from placenta or due to excessive secretion  of
hormones causing rise in blood pressure.
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Measurement of Blood pressure
DIRECT METHOD
In  animals,  cannula  or  T-tube  is  inserted  into  an  artery   and
connected  to  Mercury manometer  and pressure  is recorded  on the
kymograph, or Pressure transducer (strain gauge) which in turn is
connected to polyrite for recording.
INDIRECT METHOD
In human beings blood  pressure is measured  indirectly by using
sphygmomanometer.
Sphygmomanometer
Commonly called blood pressure apparatus, it is the instrument
used to measure blood pressure5.It consists of following  parts:
1. Manometer. Two types of manometers are used, Aneroid
manometer in which metal bellows, mechanical rings and a dial
replaces the  glass tube mercury  manometer. It is also very
commonly used nowadays. However, it needs calibration against a
mercury  manometer from  time to time.
Mercury manometer is commonly used in classical
sphygmomanometer5.It  consists of a graduated narrow  glass tube having
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markings  0 to 300mmHg.Upper end of the tube is closed and  lower end
is connected to an inflatable rubber bag through a rubber tube.
2. The cuff. The blood pressure  apparatus cuff also known  as
‘armlet’ or ‘Riva-Rocci cuff’ after the name of discoverer)
consists of  an  inflatable  rubber bag  which is enclosed  in a
cotton bag  having  a long  strip of  inelastic cloth. The
dimension of the commonly  used  rubber bag are 24cm x
12cm.It should  be atleast  as wide as half  the upper arm’s
circumference.T he bag  width (12 cm) should  be more in
obese adults ,about 4-5 cm for  children, and  2-3 cm  for the
newborns5.
3. Air pump. It is a rubber bulb with a one –way valve at its
free  end,  and  a  ‘leaky  valve’  and  a  knurled  screw  at   the
other end  where the rubber  tube  leading  to the cuff is
attached. The cuff  can be inflated  by turning the leak-valve
screw clockwise and alternatively compressing and releasing
the bulb. Deflation is achieved by turning the screw
anticlockwise.
Procedure
The blood pressure may be tested with subject lying  supine or
sitting, but should be physically  and mentally  relaxed  and free from
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excitation .The cuff of the blood pressure  apparatus is  applied  on  the
upper arm  with the centre of the rubber  bag   lying  over the  brachial
artery which lies medially, and its lower edge should  be about  3cm
above  the  elbow.
The  blood pressure  can be  measured  using  palpatory method,
oscillatory  method or  auscultatory  method5.
1. Palpatory method
Palpatory  method  described  by  Riva-Roci in  1896,includes
following  steps:
Palpate  and  feel  pulsations  of the  radial artery with the tips  of
finger of left  hand.
Keeping   fingers  of   left   hand   on  the  pulse  ,slowly   inflate   the
cuff using air pump with  the right hand until  the pulse disappears. Then
raise the pressure  further  by 30 - 40 mm Hg  in the manometer5.
Open the leak valve of air pump and  control it so that  the pressure
gradually  falls  in steps of  2-4 mm Hg. Note the reading  at  which pulse
just  reappears. This  reading corresponds  to systolic blood pressure
.After this  deflate the cuff quickly to zero  pressure.
   Take three readings  in each arm, fully  deflating  the cuff a few
minutes between  each reading .Mean of the three readings  should  be
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taken  as systolic blood pressure. The  actual pressure is usually  4-6 mm
Hg higher than the recorded value, since  initial  2-3 beats  being thin are
often  missed while feeling the pulse.
Disadvantage of  thepalpatory  method  is  that the diastolic blood
pressure  cannot be measured by this method.
2. Oscillatory  method
In this method, initial  steps  upto raising  the pressure  in the cuff
by  30-40 mmHg after the pulse disappears  are same.
Then the mercury column in the  graduated  glass tube of
manometer is carefully watched  while slowly lowering  the cuff pressure.
The oscillations  will appear and become  prominent  once  the pressure
in the cuff  is  roughly equal to the systolic pressure.
3. Auscultatory method
Auscultatory  method described by  Korotkoff in 19055, is the most
useful technique.
Initial steps upto raising the pressure in the cuff by 30-40 mmHg
above the level where the  radial artery pulse disappears  are similar to
palpatory method. However, be pre inflating the cuff, the point just before
the  brachial  artery   bifurcates  in  the  cubital   space,  just   medial  to  the
tendon of biceps muscle, is  marked.
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Then diaphragm of  stethoscope  is  placed  on the mark in cubital
space and  is  kept in  position  with the  help of  thumb  and  fingers of
left  hand.5
Pressure in the cuff is lowered  slowly by  opening  the leak  valve
of  the air  pump  with right hand. While  doing  so, initially  no  sound  is
heard . However , when  mercury  column is lowered further  a tap  sound
is heard. The  character and quality  of  sound  goes on  changing  while
further   lowering   the  mercury   column   by   deflating   the   cuff,  and
ultimately  the  sound disappears. These sounds are called Korotkoff
sounds and  from   these   the  levels   of  systolic   and   diastolic   blood
pressure  are  noted  as   described  below, when  the sounds  disappear
the  cuff should  be  deflated  quickly.
Korotkoff Sounds
Phases of  Korotkoff  sounds:
Phase I  sounds start  with a clear tap which  indicates  the systolic
blood pressure. The clear, tapping  and  sharp sounds  last for  10-12
mmHg  fall in  mercury  column5.
Phase II  sounds  are murmurish, ie  soft  and  swishing  and  last
for  next  14-15 mmHg fall in mercury column.
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Phase III  sounds are clear, knocking  and  banging  in character
and last for next  14-15 mmHg fall in mercury column.
Phase V  is labelled  when no sound is heard. Since the beginners
may not appreciate  beginning  of  muffling of  sounds and therefore
,disappearance  of  the  sound  may be considered as mark  of  diastolic
pressure. However, in some clinical situations such as  hyperthyroidism
and  aortic valve insufficiency  where  the sounds continue  to be heard
even when  the pressure is low, the level at which muffling of sounds
starts  is to be  taken  as  diastolic  blood pressure.
PHYSIOLOGIC ANATOMY OF  EAR:
Fig :1Schematic Diagram of Anatomy of  Ear
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Fig :2 Schematic Diagram of Inner Ear
The ear  is the organ of hearing and equilibrium6.It is divided into
three parts viz. The External ear, the Middle ear and the Internal ear. The
internal ear houses two organs, viz., (i) Cochlea, meant for audition
(hearing), and the (b) vestibular apparatus, meant for maintenance of
equilibrium and posture. It is to be noted that the vestibular apparatus is
not concerned with hearing. A partition wall, called the tympanic
membrane (ear drum) separates  the external ear cavity from the middle
ear cavity.
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MECHANISM OF HEARING
Fig :3 Schematic Diagram of  Organ of corti
When the sound wave travels through the medium of air, it strikes
the tympanic membrane6?  the vibration of the tympanic membrane are
transmitted through the middle ear ossicles, to reach the foot plate of
stapes ?the stapes now begins its rocking movement ? perilymph of
scala vestibule now moves ?pressure changes in the perilymph is now
transmitted through the Reissner’s membrane and endolymph of scala
media to the basilar membrane ?the basilar membrane moves up and
down ?as a result ,the hair cells are pulled and move rather side ways.
This side ways bending causes stimulation of the nerve fibers which
emerge from these hair cells and as a result ,action potential,that is ,nerve
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impulses, develop in the cochlear division of the VIIIth nerve; these
impulses on reaching the appropriate part of the brain produces the sound
perception of the subject. Two points in the above accounts need
emphasis:
i. If frequency of the sound wave is high, the basilar  membrane
vibrates only at its basal side; whereas, in low frequency sound, the
maximal vibration of basilar membrane is near its apical side.
ii. The emerging dendrons of the cochlear nerve, which are arising
from the hair cells, arise from an area of the cell which is close to
the origin of the hair. It is possible ,that a neurotransmitter bridges
the gap between the base of the hair and the origin of the nerve.
AUDITORY PATHWAYS
1. The axons of the spiral ganglion that innervate the hair cells form
the cochlear division of VIII th nerve6.The ‘auditory’ nerve enters
the medulla and ends in ventral and dorsal cochlear nuclei,thesite
of the first synapse.
2. Second order neurons from the cochlear nuclei end in superior
olive and trapezoid body on both sides of the brain stem from
where third order neurons take origin.
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3. Third order neurons pass up via a variety of pathways in the lateral
lemniscus to the  inferior colliculi of both sides.Some of these
fibers also send collaterals to the reticular formation and medial
geniculate bodies in the thalamus.
4. From the inferior colliculi many fibers project and relay in the
medial geniculate body neurons finally project to the to the primary
auditory cortex (area 41)  which lies in the superior
Portion of the temporal lobe  located in the floor of the lateral
cerebral sulcus. Here  nerve impulses are perceived as sound i.e.it
receives and perceives auditory informations such as loudness ,pitch,
source and direction of sounds.
5. Auditory association areas6 : area 22 ,21&20
(i) Area 22: Wernicke’s area. It is located in superior temporal gyrus
behind area 41, 42 in the categorical hemisphere i.e. dominant
hemisphere .It is concerned with comprehension i.e. interpretation
and  understanding of auditory and visual informations.
(ii) Area 21 and 20 .These areas are located in the middle and inferior
temporal gyrus and  are concerned  with interpretation and
integration of auditory short-term memory without impairing visual
memory.
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Fig:4 Schematic Diagram of Auditory Pathway
BIOPHYSICS:
Normal   nerve  cell  membranes   have  a  stable  resting   and   trans-
membrane  potential , because there is equal  distribution  of  positively
charged  ions outside  and  negatively  charged  ions inside  the cell
membrane. The  potential  difference  between  two  points  is 0 inspite of
a potential  difference  across the cell membrane6.The  action  potential
current   occurs,   due  to  the  movement  of   Na+  and  K+  ions  which  is
responsible for flow along the cell membrane which is resisted by the
intervening  tissue  and  this  resistance  is known  as impedance.
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Voltage = current x impedance
Voltage   represents   the  difference   of   voltage   between   two
points .The action potential  amplitude  is shown  in millivolts(mV) or
microvolts(µv) ; current  in milli-amperes (mA)  ,and  impedance in
micro-ohms  (m? ).Time   duration  are  in  milliseconds  (ms)  or
microseconds (µs). The action potential  originating  in nerves are
displayed and expressed  as wave  form ,in which amplitude  varies with
time6.
1. ELECTRODES :
(i) There are three types of electrodes : active ,reference and
ground.The action potential is measured between active and
reference electrodes whereas the ground electrodes serves as a
‘zero’ voltage reference point.
(ii) They are made up of platinum ,stainless steel, gold. Silver or gold
electrodes has the advantage of stable electrode polarization
potentials which results in noise free recording.
(iii) In clinical practice, two varieties of electrodes are used: surface
and needle electrodes. In general, surface electrode is preferred, as
using needle electrodes have a greater chance of infection.
(a) The surface electrodes are in the form of disc, cup or ring ,and are
used in nerve conduction and motor evoked potential recording.
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These electrodes are placed in position with the help of electrode
paste or jelly, which is gently rubbed on the skin and then applied
for proper contact.
(b) Needle electrode  is commonly used for EMG study6.They consist
of Teflon coated stainless steel wire which tapers to a sharp tip.
2. AMPLIFIER:
A variable degree of amplification, upto 5x10 folds is needed
before being displayed because of the following reasons:
(i) Biological signals are very small.
(ii) Intrinsic impedence of the electrode .It varies with frequency and
electrode type used. The concentric needles have a higher
impedence.
(iii) Impedence of electrode –skin.
3. FILTER :
It is a device that relatively allows a particular range of frequency
from a  signal. It is required for eliminating the noise and useful for
bringing out the characteristics of the waveforms i.e.optimising the
recording.
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(i) The low frequency filters remove the slowly changing low
frequency components and allows the higher frequencies to pass
through. Therefore, it is also called as high pass filter.
(ii) The high frequency filters remove the rapidly changing high
frequency components and allow the low frequency (upto 100 Hz)
to pass through; therefore also called low pass filters.
4. AVERAGER :
(i) It extracts very small signals which are hidden or burried in large
noise; for example:
(a) evoked potential are burried in EEG noise;and
(b) sensory nerve action potential in EMG noise.
(ii) By averaging, the time locked signals become prominent and are
stored in the memory of the equipment ,while the noise which is
occurring randomly is cancelled out. Alternatively ,the noise can be
time locked and can be rejected subsequently.
5. DISPLAY:
Two methods of waveform display are in use:
                 (i)  Analogue oscilloscope display
                 (ii) Computer based digital video display
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i. Analogue oscilloscope display6 : Here the action potential
signals are directly displayed on cathode ray oscilloscope
following amplification and filtering. It can redisplay the
waveform but certain details of  waveform may be lost.
ii. Computer based digital video display: Here an analogue to
digital converter (ADC) and digital processing  technique are
used; therefore, the signals can be redisplayed with greater
sensitivity without any loss of waveform accuracy.
6. STIMULATOR:
It is required for nerve conduction and evoked potential studies.
Two types of stimulator are in use: Electrical and Magnetic.
(i) Electrical stimulators6 : It is of two types:
(a) Constant current stimulator : It delivers a constant current  to the
subject over a wide range of stimulating electrode impedence. Thus
it is more stable and useful in repetitive nerve stimulation and
evoked potential studies.
(b) Constant voltage stimulator : It delivers a fixed voltage between
anode and cathode.
(ii) Magnetic stimulators : They are used for non-invasive stimulation
of motor cortex,spinal cord and peripheral nerves.
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7. SENSITIVITY ( or gain ) SWEEP SPEED:
The latency and duration of an action potential are influenced by
sensitivity (i.e.gain) and sweep speed.
(i) On high sensitivity ,there is shortening of latency due to
visualisation of smaller deflection from the base line.
(ii) Increase in sweep speed results in shortening of latency.
8. SIGNAL TRIGGER:
It is useful for isolating and displaying the action potentials for
their quantitative to the start of sweep.
9. DELAY TIME:
It continuously samples and stores into the memory ongoing action
potential activities6.The action potential when exceeds the triggering
values, it is extracted from the memory and displayed.
EVOKED POTENTIAL :
Evoked potential  which occurs in  the group of neurons in reaction
to  stimulation   of  a  sense  organ   which   can  be  recorded   by  surface
electrodes  are known as Evoked potential7.
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BRAINSTEM  AUDITORY  EVOKED POTENTIAL:
Brainstem   auditory   evoked  potential  uses  a  click  stimulus  that
produces a sequential  activation  of brainstem  auditory  pathway ( ie)
reaction   from  the  cochlea,  the   signal   that   goes  along   the  auditory
pathway  from the cochlear  nuclear  complex  to the inferior colliculus in
midbrain generates wave 1 to 5 ; occurring  10 milliseconds after auditory
stimuli.
Brainstem   Auditory   Evoked  Potentials  /  Auditory   Brainstem
Response (ABR).
The potentials recorded from the ear and vertex in response to a
brief auditory stimulation are called Brainstem Auditory Evoked
Potentials7.These are produced within 10msec. by a brief click stimulus.
A series of potentials are generated corresponding to sequential activation
of peripheral, pontomedullary, pontine and midbrain portion of auditory
pathway. It helps to assess:
(i) Conduction through the auditory pathway upto midbrain.
(ii) Severity of hearing deficits; and
(iii) Middle portion of brainstem functions.
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USES OF BAEP: Clinically BAEPs are used :
1. To assess hearing  in uncooperative patients  and very young
children.
2. To detect degree of hearing loss in infants.
3. To assess the functions of the midpart of the brainstem.
The axons of the spiral ganglion that innervate hair cells of the ear
form the cochlear nerve. The first order of neurons terminates in the
cochlear nuclei in the medulla from where the second order of neurons
arises and ends in the superior olivary nucleus. The third order of neurons
originates  from the superior olivary nucleus  and ascends  the lateral
leminiscus to project  onto the inferior colliculus which is the centre for
auditory reflexes. From the inferior colliculi, many fibres project to the
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medial geniculate body in the thalamus and from there to the primary
auditory cortex (area41)7.
Waves of BAEP
Five or more distinct waveforms are recorded within 10ms  of the
auditory stimulus. These waveforms are named wave I,II,III IV and V.If
the recording continues ,a few more positive and negative waves are
recorded.
Wave I :Orginates from the peripheral portion of the eighth cranial
nerve adjacent to the cochlea.
Wave II :Orginates from the cochlear nucleus.
Wave III :Orginates from the superior olivary nucleus.
Wave  IV : Orginates  from the  lateral lemniscus.
Wave V :Orginates from the inferior colliculi.
Factors that affect BAEP
1. Age  The latency of BAEP is affected by age, especially in early
childhood. Latency is age dependent up to two years. The  effect of
age is more pronounced in  premature infants. Older adults have
slightly longer I to IV interpeak latency compared  to younger
individuals7.
2. Sex   Women have shorter latency and higher amplitude of BAEPs.
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3.   Height   The  height  of  the  subject  has  no  direct  correlation   with
latency or amplitude of BAEPs.
4. Temperature  Increased body temperature decreases the latency
and decreased temperature increases the latency of BAEP.
5. Drugs  Barbiturates and alcohol prolong the latency of wave V.
These drugs affect latency by decreasing the body temperature
instead of directly acting on the auditory pathway.
6. Hearing loss  Hearing deficit affects BAEPs. Therefore, hearing
tests, especially  to detect conductive deafness and examination of
the ear to diagnose ear block by  cerumin, should be done prior to
recording BAEPs.
Fig : 5 Schematic Diagram of Wave forms
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Wave I
Characteristics
1. This is the first prominent upgoing  peak in the ipsilateral  ear
recording channel. It is reduced or absent from the contralateral ear
recording channel.
2. It appears 1.4 ms after the stimulus.
3. The amplitude of this wave can be increased by using horizontal
montage, external canal needle electrode, nasopharyngeal
electrode, increasing stimulus intensity or decreasing the stimulus
rate.
Clinical application    As it originates  from the eighth nerve this
wave is preserved in patients who have only central problems. But, those
who have peripheral hearing impairment have reduced or absent wave I.
(wave II to V remain relatively normal).
Wave II
Characteristics
1. This is a poorly defined wave.
2. It appears as a  small peak following wave I. It may appear in the
downgoing slope of wave I or in the up going slope of wave III.
3. It is more prominent in the contralateral channel recording where it
has a slightly prolonged latency compared to the ipsilateral
recording.
Clinical application It is absent in lesions of the cochlear nucleus7.
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Wave III
Characteristics
1. This is a prominent up going peak.
2. It is smaller and appears  earlier in the  contralateral  channel.
3. It may  sometimes  appear as a bifid wave ( with two peaks ).
Clinical application    It is reduced or absent in lesions of  the superior
olivary nucleus.
Wave IV
Characteristics
1. This is a very small wave that usually appears in the up going
slope of wave V.
2. Sometimes it may be absent or may appear as a very small wave at
the peak of wave V giving  it a bifid appearance.
Clinical  application    It is absent in lesions of the lateral lemniscus.
Wave V
Characteristics
1. This is the most prominent peak in BAEP.
2. It appears 5.5 ms after the stimulus.
3. It starts usually above the baseline immediately following wave IV.
Clinical application It  disappears in diseases affecting  the inferior
colliculi.
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Abnormal BAEPs: abnormalities include:
(i) Absence of wave I :It is seen in
(a) Large tumour damaging VIII nerve
(b) VIII nerve ischemia
(ii) Absence of waves beyond wave I :
Causes : (a)  acoustic neuroma
(b)  Meningioma
(c)  Demyelinating disorders.
(iii) Absence of waves IV and V:
Causes: (a) multiple sclerosis
(b) hydrocephalous
(c) The right to left latency asymmetry exceeding
0.5msecis seen in acoustic neuroma.
Measurement of BAEP waveforms
The following parameters are measured for analysing the
waveforms of  BAEPs:
1. Absolute  latency and amplitude
2. Interpeak latencies
3. Amplitude ratio of V/I
4. Inter – ear –interpeak difference.
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Absolute latency and amplitude
The absolute amplitude is measured as the height from the peak of
the wave to the trough  of that wave. The absolute latency  is measured as
the distance ( expressed in ms) from the beginning of the first wave to the
peak of that wave.
Interpeak  latencies
The interpeak latencies (IPLs) commonly measured are I-V, I-III
and III –V. This is measured as the difference  between the peak of both
the waves(expressed in ms)7.
I – V interpeak latency
1. The normal value is 4.5 ms.
2. It represents conduction from the proximal part of the eigth
nerve through pons to the midbrain.
3. It is slightly  less in females and more in elderly men.
4. It is prolonged in :
? Demyelination
? Degenerative diseases
? Hypoxic brain damage
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I – III interpeak latency
1. The normal  value is about2.5 ms.
2. It measures conduction from  the eigth nerve across the
subarachnoid space into the core of lower pons.
3. It is prolonged in:
? Inflammation or tumour of the eigth nerve
? Disease at the pontomedullary junction
? Guillain – Barre syndrome.
III – V interpeak latency
1. The normal value is about 2.4ms.
2. It measures conduction from the lower pons to the midbrain.
3. It is prolonged in  prolongation of I –V  IPL. The isolated
prolongation III – V IPL is not considered significant.
Amplitude ratio of V/I
Wave I is generated outside and V is generated inside the CNS.
Therefore, the V/I ratio compares the relationship of the signal amplitude.
Normal value  The ratio is normally between 50 percent and 300
percent.
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Clinical implication If the ratio is less than 50 percent, this
suggests small wave V, which indicates a central impairment of hearing.
If  the  ratio  is  more  than  300  percent  ,this  suggests  small  amplitude  of
wave I, which indicates peripheral hearing impairment.
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REVIEW OF LITERATURE
Neurophysiology of Evoked Potentials :
The first human brainstem auditory evoked potential was fully
described by Jewett and Williston in 1971, and Sohmer and Feinmesser in
1967 attributed their origin in evoked potential.
The developments in clinical neurophysiology are related  to
invention of electricity. Lugigalvani in 1971 discovered that nerves were
a good  conductor of electricity.
Duchene in 1833 discovered the neuromuscular disease and
developed the techniques for electrical stimulation.
Helmholtz measured the conduction velocity of nerve in frog by
mechanically recording the muscle twitch in 1850.
Carlo Matteucci from Italy investigated the muscle nerve
preparation  and formulated the electrophysiological  concept based
functioning of the nervous system.
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Du Bois Raymond in 1851, recorded  the action potential of
voluntarily contracting muscle using  jars of liquid  as eletrodes which
was the beginning  of electromyography.
Erb  in 1861 was the first  to find the method of electro diagnosis
based on faradic and galvanic current. He was the one who demonstrated
the increased electrical irritiblity of motor nerves in tetany, known as
Erb’s phenomenon.
In 1994, Williams GH1, stated that in essential hypertension
auditory evoked potential wave abnormalities are common due to central
nervous system dysfunctions.
In 1996, O.P.Tandon, Daya Ram &R.Aswathi2 stated that
Brainstem auditory evoked potential responses  were recorded from
essential hypertensives and showed significant prolongation of absolute
peak latencies of wave I,II,V  and interpeak latency of wave III-V
indicating involvement of brainstem auditory pathways.
In 1999, Chen Y L, Ding3 Y P  a case control study was carried out
in Kenya with 50 elderly, hypertensive with ABR showed a relationship
between hearing loss and arterial hypertension.
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In 1990, Markova M.8 Stated that a report was submitted after
analyzation of  50 hypertensives with hearing impairement showed
arterial hypertension is an important risk factor for hearing loss.
In 2004, Baraldi GS, Almeida LC,Borgea9 ACLC observed that the
systemic arterial hypertension and hearing loss have important prevalence
in elderly population.
In 1989, Katz J10. Says that proper supply of oxygen and nutrients
are needed to  maintain  alive of human body ,and maintain structure and
functional  integrity of  heart and blood vessels.
In 1983,Nagahar K, Fisch U, Yagi N11 stated that Hypertension ,the
most common cause for structural change in heart and blood vessels
.
In 1996, Rarey KE,  YL, Gerhardt KJ, Fregly MJ, Garg LC, Rybak
LP.12 Observed that arterial hypertension causes ionic changes in cell
potentials causes hearing loss.
In 2004,Ferrerira DR13, Silva AA,Kornet L, Hoeks APG, Janssen
BJA, Major factor affects health today is chronic diseases caused by
genetics, life style, environment and aging itself. for maintaining their
physical and mental functions until close to death we shouldpay attention
on their healthy life.
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In 2001,Bachor E14, selig YK, Jahnke K, Rettinger G, Kaemody Cs
stated that progressive or sudden hearing loss is caused by high pressure
in vascular system cause inner ear damage which is supplied by anterior
inferior cerebellar artery  supports the inner ear artery divided into
cochlear artery and anterior vestibular artery.
In 1994, Ohinata Y15, Makimoto K, Kawakami M, Takahashi H.
Stated that  the pathophysiology underlying hearing complaint in
hypertension  is Due to increased blood viscosity  it reduces capillary
blood flow and it reduces oxygen transport causing tissue hypoxia.
In 1998,Antikainen RL16, Jousilahti, P,Tuomilehto J, Observed that
methodology of  study is focused on middle aged individual  and
excludes specific disease which impairs hearing.
In 1990, Carrasco VN17, Prazma J, Faber JE.Gates GA, Cobb JL,D’
Agostinho RB, Wolf  PA 1993,Stated that the cause for sensorineural
hearing loss with aging is due to microcirculatory insufficiency due to
vascular occlution caused by emboli, haemorrhage or vasospasm  because
of microangiopathy caused by hypertension.
In 2003,Marchiori LLM18, Gibrin PCD ,Collet L, Berger –Vachon
C, Desreux V, Morogon A. Cochlear degeneration in hearing loss  is due
to environmental factors, may be subject, such as noise, inhalation of
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toxic substances, metabolic and circulatory alterations, infections, genetic
inheritance.
JNC – VII Hypertension19 2003; controls and hypertensive subjects
systolic and diastolic BP were measured according to this Joint National
Committee.
In 1996, Karamitos DG, Kounis NG, Zarvras GM, et20 observed
that 30 ischemic heart disease patients showed significant change in peak
latency and inter peak latency, BAEPs become noninvasive assessment
for essential hypertension and IHD.
In 1990, Sismanis21A, Callari RH, Slomka WS, etal.stated that
pathophysiology of auditory evoked potential inn essential hypertension
is stretching –compression of cochlear nerve in brainstem due to
intracranial hypertension.
Julius S, Petrin J22. Autonomic nervous and behavioralfactors in
hypertension. In Hypertension: Pathophysiology, Diagnosis and
management. LaraghOHanaBrenner BM (Eds) Raven Press Ltd.
NewYork 1990: PP2083-2090.
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In 2003, Guidelines committee ,European Society of
Hypertension23 –European Society of Cardiology  guidelines for the
management of  arterial hypertension. .
In 1986, Hashimotto et al,24 In 1982,Mbller AR, Jannetta PJ 25
observed that lesion of tegmentum of lateral pontomedullary junction
lead to changes in ipsilateral BAEP after wave II.
In 1975, star and achor26were the first  to report  the effects  on the
ABR of CNS pathology in the brainstem.
In 1994 , Marsh and Smith27 has shown that raised blood pressure
in pre –eclamptic  women may affect vascular responses of the blood
vessels in brain and cause ischemic delay in P1 latency of  visual evoked
potentials.
In 1994, Sethi A, and Vaney N,28 in brainstem auditory evoked
potential proved that there is decreased  sensory conduction because of
cold pressure response.
Fisher CM.29 Cerebral miliary aneurisms in hypertension.
Am ,]Paihol 1972; 6G: 313.
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In 1971 ,Frederic MW30. Stated that the basic mechanism for
central nervous system dysfunction in hypertension due to  arterial and
arteriolar spasm of cerebral blood vessels, combined microinfarction,
fibrinoid degeneration and brain oedema in severe cases.
In 1982, McGhee TB31, observed that hypertension induced central
nervous system dysfunctions in the form of sensory or motor deficits,
presents with symptoms of occipital headache, dizziness, vertigo tinnitus
reduced vision.
In 1994, Pavfilov V V,Reid  JL32.stated that essential hypertension
leads to dysfunction in mechanism of brainstem so it leads to sensory
deficits due to interaction of sensory  neuronal substrate.
Ziegler DK33. Hypertensive vascular disease in the brain.In Hand
book of clinical neurology Vinken P,J, Bruyn GW (Ed) Elsevier
Publishing Company New York 1972;12 : 552.
In 1981 OH SJ, Kuba T, Soyer A, Choi  IS, Bonikowski FP, Vitek
J34 Stated that brainstem auditory evoked potentials are lateralisation of
brainstem lesions.
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In  1979,   Nago  S,  Roccaforte   P,  Moody  RA35 ,observed that in
experimental transtentorial  herniation presents with unilateral pupillary
dilatation and  auditory evoked response showed changes in wave V.
In 1980, Tsubokawa T, Nishimoto H, Yamamoto T,et al36stated
that to assess prognosis of  comatose patients with brainstem auditory
evoked potential  is used for number of cases.
In 1982, Karnaze DS, Marshall LF,McCarthy CS, et al 37 stated
that after closed head injury in coma for localisation and prognostic value
monitored by auditory evoked response.
In 1975, Starr A, Achor LJ38:  observed that reversible brainstem
dysfunction and  non reversible brain dysfunction  has been differentiated
by brainstem auditory evoked response.
In 1982, Hall JW, Huang –Fu M, Gennarelli TA39: stated that
auditory function in acute severe head injury is monitored with auditory
evoked response waves.
In 1985, Scherg M, Cramon D von40 .observed that the wave
generators of BAEP located in tegmentum of upper medulla and
pons.BAEPs are very sensitive for detection of pontine haemorrhage.
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In 1986, Stockard JJ, In 1977 Rossitter (Stockard JE, Sharbrough
FW, J.J., J.F. Hughes41,42,43, stated that brainstem auditory evoked
potential gives the information Of methodology, interpretation, and
clinical application .
In 1985, Hammond EJ, Wilder BJ, Goodman IJ, Hunter SB44, the
study of BAEP and pontine haemorrhage have prognostic value and
correlation of evoked potential findings with clinical signs and
localization of lesion.
In 1980,Maurer et al45,and Stocked et al 1986,observed that
generators of wave limited by rarefaction and condensation clicks it may
provide different value from same patient.
 In 1981, Hashimoto I, Ishiyama Y, Yoshimoto T, Nemoto  S46
,observed that haemorrhage in right tegmental pontine region BAEP
showed loss of wave V after contralateral ear stimulation.
In1980, Hashimoto, I.,Y. Ishiyama, G.Totsuka&
H.Mizutani47.stated that more specific test for monitoring auditory
function is intraoperative BAEP useful in microvascular decompression
of CN V and CN VII.
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In 1983, Chiappa48, stated that  lateralisation of  BAEPs seen in
unilateral bleeding in the pontinetegmentum on ipsilateral side. In
demyelinating disease delayed latency of peaks  and reduction of
amplitudes and loss of waves are seen.
In   1996,  Sabbatini  M,  Vega  JA ,  Amenta  F49.  Stated  that  animal
studies also consistent with development of neuropathy with
hypertension, there is luminal narrowing leads to reduced vascular supply
in hypertensive rats.
In 2001,   Sabbatini  M, Bellagamba G, Vega JA50, et al  observed
that peripheral neuropathy in hypertensive rats are improved with
antihypertensive treatment.
In  2004,Tomassoni  D,  Traini  E,  Vitaioli  L,  et  al51 observed that
hypertensive rats shows peripheral neuropathy and decreased nerve
conduction velocity and reduced percentage of class I fibers and
increased percentage of class II & IV fibers in sciatic nerve of
spontaneously hypertensive rats.
In 1983,Kanaya H, Saiki I, Ohuchi T, KamataK, Endo H,
Mizukami M, Kagawa M,Kaneko M52 Intracerebral haemorrhage in
essential hypertension involves putamen, and extends into internal
capsule it  produce abnormal waves in BERA.
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In 2001, Wang J, Liu YS, Liu SM53. Observed that significant
prolongation in wave IV, V and VII presents with ABR also seen in
rabbits with intra cranial hypertension.
In 1992, Picton TW, Taylor MJ54, abnormality in BAEPs depends
metabolism and myelination of CNS, so hypertension metabolic
alteration in these produce abnormal latencies and inter peak latencies.
In 1986, Cant et al 55 stated that auditory pathway destruction leads
to loss of BAEP waves not only due to compression of brainstem and also
more likely a lesion of whole brainstem at the level of generator of
altered wave, including structures lying rostral to this level.
In 1974 ,Hecox and Galambo56 showed that the ABR could be used
for threshold estimation in adults and infants.
In 1998, Souza LCA, PizaMRT, Machado CSS, Barcelos WCO,
Britto DBO57, Stated that BAEP is the instrument for assessing brainstem
function in coma  to predict the prognosis and diagnosis.
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AIM  AND OBJECTIVE
AIM :
To evaluate Brainstem  Auditory Response in  Essential
Hypertension.
Objective :
To use Brainstem auditory evoked potential as tool to measure the
subclinical abnormalities in patients with Essential Hypertension.
To assess  the latencies and interpeak latencies in patients with
Essential Hypertension.
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MATERIALS AND METHODS
This study was conducted  at the Institute of  Physiology, Kilpauk
Medical College, Chennai.
Study Design: Case control study.
Subject selection : Total sample size -80 , Essential hypertensive
patients -40 ; controls – 40.
INCLUSION  CRITERIA :
* Patients with Essential hypertension diagnosed by the department
of  medicine, Kilpauk Medical College.
Male &Female  between 40 – 60 years.
* Written informed consent.
Exclusion Criteria :
? Ischemic heart disease.
? Diabetes mellitus.
? Cerebro vascular disease.
? Alcoholism.
? Any neurological diseases.
? Renal disease.
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? Hearing impairment.
? Drugs causing ototoxicity.
? Vitamin deficiency.
? Drugs causing neuropathy.
? Thyroid disorders.
? H/O Antiepileptics.
CONTROL -  Healthy volunteers who are age & sex matched  will
be choosen as controls.
Screening procedures :
? Patients who qualify under the inclusion criteria will be enrolled in
the study.
? Heart rate.
? Blood pressure .
? Height.
? Weight .
? Brief history to rule out ,diabetes ,IHD ,alcoholism ,drug intake.
? General clinical examination
EQUIPMENT DETAILS :
Brainstem  auditory  response  studies  will  be  carried  out  on  a
computerised Nerve conduction testing equipment: Medicaid,
computerised physiolab, Neuroperfect  plus
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INSTRUMENT  - MEDICAID – NEUROPERFECT  PLUS
Ethical Considerations :
Institutional Ethical committee approval was obtained from
Kilpauk  Medical College Chennai – 10.
Subjects : The subjects were made to relax themselves before the
test.The procedure and objective for this study was explained in  their
own language.A detailed clinical history about hypertension was
collected from them. The written and informed consent was obtained
prior to the  individual were subjected to the study.The complete
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examination of the ear was done for both the ears. Blood pressure
measured for both control and subjects. The basic parameters of  the
subjects like height ,weight ,and pulsewas recorded. Brainstem auditory
evoked potential were recorded in 40 hypertensive patients and 40 control
of both the genders. Toestablish the reliability of the method,
severalrepititions of auditory evoked potential recordings were done.
Precautions :
1. The subject should be properly instructed and motivated to provide
full cooperation.
2. The room should be quiet and comfortable.
3. The skin of the scalp and mastoid should be grease free.
PREREQUISITES  FOR THIS STUDY :
? The subjects were adviced  to have a head bath with shampoo prior
to the test.
? The individuals are adviced not to apply oil or hair spray on  their
head.
? The  research room was made  comfortable to the subjects ,calm
and  uniform temperature  maintained.
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? Subjects were instructed to sit on the wooden chair and keep their
leg on the wooden  block.
? They were instructed  to remove their ornaments from the ear, neck
and hand.
PROCEDURE: The recording of BAEP was done in
Neurophysiology research laboratory, Department of physiology , Kilpuk
Medical College using Neuropefect Plus – Medicaid Physiolab. The  left
and right ears  were tested  separately in all subjects.
RECORDING OF BAEP – INSTRUMENT SETTING
Requirements :
1. Recording  electrodes
2. Amplifier and  average
3. Electrode paste
4. Earphone.
Equipment set up:
Suggested Montage :
1. Channel : Ai – Cz  - Active electrodes
60
2. Channel : Ac – Cz – Ipsillateral ear (Ai), Contralateral ear
(Ac) or mastoid process.
3. Ground  : Fz  -  Reference electrode ; Cz i.e.at vertex ( it is
regarded  as a suitable location as waves II-V have a good
amplitude at the vertex)
Recording conditions:
1. Filter
a. Low filter cut :10 -100 Hz.
b. High filter cut :3000Hz.
2. Amplification between 2,00,000 – 5,00,000
3. Sweep speed :1 msec/division.
4. Number of epochs :at least 100.
5. Electrodeimpedence should be kept below 5 kilo-ohms.
Stimulation options:
1. Sensitivity : 0.3 uv /division
2. 60db sensory level i.e.point at which the individual can
barely appreciate the  stimulus.
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B.Steps :
1. Keep the instrument out of view of the subject.
2. Allow the subject to sit comfortably on a chair in a fully
relaxed state.
3. The skin at the point of placement of electrodes is cleaned
with ether or spirit.
4. Using electrodes paste or conducting jelly ,the recording
(active) electrode are placed on both the ears, ipsilateral (Ai)
and contralateral  ear(Ac) or mastoid process as per 10 – 20
international  system  of  EEG   electrode   placement  ;   the
reference electrode is placed at the vertex i.e.at Cz ; the
ground  electrode is placed at Fz
5. Check the equipment set up as per technical
recommendation of BAEP study.
6. The electrodes are connected through the preamplifier to the
cathode-ray oscilloscope (C.R.O)
7.  Give  a  brief  click  stimulus  which  is  usually  a  square  wave
pulse of 0.1 msecduration.A click rate of 11-31 Hz are most
commonly used in clinical practice.
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8. Observe the effect of click intensity on BAEP .Analyse the
BAEPs wave form and compare with the normal.
ElectroPhysiological  Study:
Brainstem  auditory evoked potential (BAEPs) constitute an
objective hearing test6. These are the potentials recorded from the ear and
the scalp in response to a brief auditory stimulation .The evoked
potentials that appear following transduction of the acoustic stimulus by
the ear cells ,create an electrical signal that is carried  through the
auditory pathway to the brainstem and from there to the cerebral cortex.
When the signal travels, it generates action potential in all the fibres.
These action potentials can be recorded at several points along the
auditory pathway and even from the surface of thebody. BAEP assess
conduction of the impulse through the auditory pathway up to the
midbrain6.
PARAMETERS  STUDIED :The  wave latency  I ,II,III,IV, V and inter
peak latency I-III,I-V, and III-V of waves were measured. The wave
pattern in recording BAEP is 5 or more peaks within  10ms of  stimulus.
Initial 5 peaks have clinical  value.
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TABLE – 2
Anthropometric Measurements of cases (Hypertensives) with
controls
Variables
Cases n=40
Mean ± SD
Controls  n=40
Mean ± SD
P value
Age (yrs) 52.02 ± 5.34 51.74 ± 4.61 .80
Height (cm) 159.45 ± 2.69 158.0 ± 3.260 .34
Weight (kgs) 62.50 ± 3.58 59.33± 2.08 .00
BMI (Kg/m2) 24.59 ± 1.56 23.78 ± .91 .006
BMI – Body Mass Index
The parameters were analyzed using student independent ‘t’ test.
P < 0.05 is taken as significant.
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Fig :3
Anthropometric Measurements of  cases (Hypertensives) with
controls
65
TABLE - 3
COMPARISON OF BLOOD PRESSURE IN CASE AND
CONTROL
CASE CONTROL P  value
SYSTOLIC BP 159.6 ± 14.4 101.4 ± 8.31 .000
DIASTOLIC  BP 122.8 ± 6.40 85.2±5.57 .000
The parameters were analysed using student independent ‘t’ test.
 P <0.05 is taken as significant.
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Fig:4
COMPARISON OF BLOOD PRESSURE IN HYPERTENSIVE
SUBJECT AND CONTROL
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TABLE – 4
FREQUENCY DISTRIBUTION OF HYPERTENSIVE CASES
Category No of Patients Systolic  BP(mm Hg)
Diastolic BP
(mm Hg)
Stage   I 20 140 – 159 90 – 99
Stage   II 12 160 – 179 100 – 109
Stage  III 8 180 – 209 110 – 119
Stage  IV 0 >210 >120
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TABLE -5
COMPARISON OF ABSOLUTE PEAK LATENCIES BETWEEN
HYPERTENSIVE SUBJECTS AND CONTROL  OF RIGHT EAR
Latencies
(ms)
Case
n=40
Mean±SD
Control
n=40
Mean±SD
t  value P value
I 1.48±.59 1.25±.177 2.403 .019
II 2.05±.46 1.83±.40 2.213 .030
III 1.97±.46 1.736±.401 2.498 .015
IV 2.55±.581 2.107±.284 4.28 .000**
V 3.636±.98 2.742±.533 4.287 .000**
P< 0.05 is taken as significant.
P<0.01 is taken as highly significant.
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Fig :5
COMPARISON OF ABSOLUTE PEAK LATENCIES BETWEEN
HYPERTENSIVE SUBJECTS AND CONTROL   OF RIGHT EAR
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TABLE-6
COMPARISON OF INTERPEAK LATENCIES BETWEEN
HYPERTENSIVE SUBJECTS AND CONTROL OF RIGHT EAR
Inter peak
latencies
Case
N=40
Mean±SD
Control
N=40
Mean±SD
t  value P value
I – III 4.03±1.19 3.03±.548 4.767 .000**
III – V 1.19±.480 .95±.460 2.269 .26
I-V 1.48±.69 .92±.399 4.388 .000**
P<0.05 is taken as significant.
P < 0.01 is taken as highly significant.
71
Fig :6
COMPARISON OF INTERPEAK LATENCIES BETWEEN
HYPERTENSIVE SUBJECTS AND CONTROL OF RIGHT EAR
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TABLE -7
COMPARISON OF ABSOLUTE PEAK LATENCIES BETWEEN
HYPERTENSIVE SUBJECTS AND CONTROL OF LEFT EAR
Latencies(ms)
Case
N =40
Mean±SD
Control
N =40
Mean±SD
t  test P value
I 1.48±.460 1.205±.188 2.674 .009
II 2.046±.459 1.832±.398 2.213 .030
III 2.630±.538 2.20±.356 4.104 .060
IV 3.669±.985 2.935±.65 3.895 .070
V 4.121±1.11 3.284±.674 4.255 .000*
P<0.05 is taken as significant.
P < 0.01 is taken as highly significant.
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Fig : 8
COMPARISON OF ABSOLUTE PEAK LATENCIES BETWEEN
HYPERTENSIVE SUBJECTS AND CONTROL OF LEFT EAR
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TABLE - 8
COMPARISON OF INTERPEAK LATENCIES BETWEEN
HYPERTENSIVE SUBJECTSAND  CONTROL OF LEFT EAR
Inter peak
latency
Case Control t  value P value
I-III 1.166±.404 .942±.38 2.504 .014
III-V 1.519±.730 .985±.474 3.838 .000**
V-I 2.614±.823 1.89±.698 4.163 .000**
P<0.05 is taken as significant value.
P < 0.01 is taken as highly significant.
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Fig : 7
COMPARISON OF INTERPEAK LATENCIES BETWEEN CASE
AND  CONTROL OF LEFT EAR
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BRAINSTEM  AUDITORY  EVOKED  POTENTIAL
RECORDING OF A SUBJECT
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BRAINSTEM AUDITORY EVOKED POTENTIAL RECORDING
OF A SUBJECT
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RECORDING OF BAEP WAVE FORMS IN RIGHT EAR
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RECORDING  OF BAEP  WAVE FORMS IN LEFT EAR
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RESULT
Control Group : There were 40 cases in this control group  average
age 51.74 ± 4.61 yrs, average weight of 59.33 ± 2.08, average height in
cm 158.0 ± 3.260 ,systolic BP 101.4 ± 8.31, Diastolic BP 85.2 ±
5.57.Since the values of BAEPs of  Right and Left ears did not vary
significantly, average of two ears was calculated and these absolute peak
latencies and inter peak latencies are given in table 5 ,6 ,7 & 8.
Hypertensive Group : There are 40 Primary  Hypertensive patients
ranging  from 40 – 60 years of age with an average age of 52.02 ± 5.34
yr, average weight 62.50 ± 3.58 Kg, Height 159 .45 ± 2.69 cm ,Systolic
BP 159 .6 ± 14.4 mmHg, Diastolic BP 122.8 ± 6.40 mmHg.
Hypertensive  subjects were graded on the basis of raised BP ,as
per criteria laid down by seventh report of the joint national committee on
selection, evaluation and treatment of high blood pressure(15) .The average
value of BAEPs  two ears of  absolute peak latencies are given in table
5,7interpeak latencies of  both ears are given in table 6 & 8.
    The female subjects both in control and hypertensive group had
slightly lower values of BAEPs  as compared to males but as these were
not statistically significant. Composite data in each group were given in
the tables.
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  In hypertensive group comprising of 40 cases ,8 cases belongs to
stage III hypertensives showed abnormal BAEPs . All other cases of stage
I ( n=20), stage II (n=12) did not show significant change in latencies and
amplitudes of waves when compared with controls.( Table 5,6,7,8 )
Significant increase in absolute  peak latencies in Right Ear on
wave I ,III IV &V & inter peak latencies of wave ( I – III)  & ( I – V).
Left  Ear – increased absolute peak latency of  wave I,  &V & inter
peak latencies on ( III – V)& (V –I).
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DISCUSSION
The aim of our study was to evaluate the effect of hypertension on
ABRs, 40 patients with primary hypertension were selected between ages
of 40 – 60 yrs ,along with 40 age and sex matched  normotensives. In  our
study auditory threshold  increased significantly.
In a study done by O.P.Tandon2 et al, auditory evoked potential in
stage – III essential hypertension showed, significantly prolonged
absolute peak latency in wave I, II &V and  Prolonged inter peak latency
in wave (III -V)
Another study by Shilpakhullar, Navingupta and Rashmi Babbar et
al, Auditory brainstem responses and Nerve conduction velocity in
Essential Hypertension showed  significantly increased  absolute peak
latencies of waves I, II & V compared to controls and  increased IPL in
wave  (  III  –V).  There  is  also  another  study   that  showed  increased
latencies of wave V, inter peak latency (V-I) and wave (III-V) were
prolonged compared with normal elderly subjects.
Karamitos20 et  al,  studied  ABRs  and  measured  the  parameters  of
APL waves I to V and IPL (I-III), (III-V) & (V-I), and he found measured
absolute peak latencies and interpeak latencies were significantly
increased. Hence BAEPs become part of noninvasive assessment for IHD
and Essential hypertensive subjects.20
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There  is  another  study  wang  J53 et al showed significant
prolongation  of  waves  IV,V  &  VII  of  ABRs,  were  seen  in  rabbits  with
intracranial hypertension compared with controls. These abnormalities
due to stretching –compression of cochlear nerve in brainstem, because of
intracranial hypertension or primary edema.17
Similar correlation of Increased in P1 latency of VEP with
increased BP in preeclamptic women has been reported recently by
Marsh MS, SmithS et al27.. This finding suggest that incidence of BAEP
becoming abnormal increases with  severity of hypertension. This present
study concludes that sensory dysfunction of auditory pathway is at the
level of brainstem in hypertension.34
There  is  a  study  Sethi  N,  Vaney  et  al 28 reported that decreased
sensory conduction during cold pressure response in humans .A few
studies showed correlation between metabolic disorders &abnormalities
in  BAEPs. Some studies says that sensorineural hearing loss with aging
is because of microcirculatory insufficiency due to vascular occlusion
caused by emboli, haemorrhage, or vasospasm collectively called
syndrome of hyperviscosity15 or microangiopathy caused by hypertension
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CONCLUSION
It is concluded that rise in blood pressure affects sensory
conduction in the auditory pathway in the brainstem  it prolongs the
latencies indicating more involvement of 8th Nerve.
So, this study suggests that early screening by Electro
Physiological Test may preferably be done to prevent the Hearing
impairment at an early stage. It has been proved that BAEP is a valuable
method to detect early involvement of auditory pathway. Hence it is
considered as useful screening tests for hypertensive subjects. More detail
investigations involving BAEP in relation to various diseases have to
come up in future.
Future avenues in BAEP:
As the sample size of this study involves small group, further
studies are needed in a larger group of individuals to confirm findings.
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ANNEXURE
PROFORMA
Proforma  for the study subject : Date:
1.S.NO :
2.Name :
3.I.D (given by investigator) :                             Contact No.
4.Age :
5.Gender :
6.DiabetologyDept .No. /Master Health checkup no:
7.Occupation : None /Housewife/labourer /professional/others(specify):
8.Religion : : Hindu / Muslim / Christian / Others (specify):
9.Family History of Diabetes : Parents / siblings
10.Educational Qualification : No education /Class I-V  /VI – XII
/College /Professional:
11.Per Capita Income :
              Number of  family members :
              Net family income :
12.Type of House : Kutcha / Pucca /Semi
13.Amenities at house : Cycle /motorcycle
/fridge/electricity/car/mobile/telephone./mobile no:
14.Duration of illness:
15.Social Habits :
92
Past/Present/Newer   Brand /
quantity
         Duration
1.Smoking
2.Alcohol
Clinical Details:
16.Symptoms :                                                             Duration :
? Increased Appetite:
? Thirst :
? Increased Urination :
? Loss of weight :
? Tingling & Numbness :
? Paresthesia :
? Location :
? Giddiness:
? Skin ailments :
? ENT ailments – Ear Discharge / Wax / Hearing impairment
? Visual Impairment:
17.On Examination :
? Height :
? Weight :
? BMI :
? Blood Pressure :
? Built :
93
? Nourishment :
? Central Obesity :
? Waist Hip Ratio ;
Final Diagnosis :
    Primary Hypertension
Complication :
18.Audiological Examination :
1.Examination of the External Auditory Meatus :
2.Examination of the Tympanic Membrane :
3.Tuning fork tests :
a.Rinnie Test :
b.Weber test :
4.Pure Tone Audiometry :
a.Right ear :
b.Left ear :
20.Brainstem Auditory Evoked Response :
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   Variables Right Ear Left Ear
Latency of  waves ( ms)
         I
        II
        III
        IV
         V
Inter-peak latency (ms)
         I -  III
         I – V
         III – V
95
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INFORMED CONSENT
I undersigned agree  to participate in the study entitled ‘’Evaluation
of Brainstem Auditory Evoked response in Essential Hypertension’’. All
the procedures of the study and possible adverse effects have been
explained to me before the test.
Date : Sign of Investigator:
Sign .of  Patients :
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LEFT EAR RIGHT EAR
S.No Age Sex
Height
(cm)
Weight(
Kg) BMI
Systolic
BP
Diastolic
BP
Wave
I
Wave
II
Wave
III
Wave
IV
 Wave
V
IPL
I-III IPL III-V IPL V-I
Wave
I
Wave
II
Wave
III
Wave
IV
Wave
V
 IPL
I-III   IPL III-V  IPL V-I
1 55 M 163 55 20.7 186 118 2.8 3.08 3.38 4.6 5.88 0.58 2.5 3.08 2.38 2.08 2.62 6.2 5.68 0.24 3.06 2.3
2 52 F 158 68 27.24 180 112 2.78 2.58 3.42 6 6.02 0.44 2.6 3.3 1.8 2.3 3.9 5.02 5.5 2.1 1.6 3.7
3 58 M 162 70 26.67 186 118 2.6 2.45 3.48 5.4 5.55 0.88 2.07 1.95 1.65 2.62 3.45 4.53 5.1 1.8 1.55 3.35
4 50 F 158 62 24.84 184 110 2.2 2.72 3.08 5.45 5.98 1.78 2.9 3.78 1.9 2.08 3.05 4.6 5.72 1.15 2.67 3.82
5 46 F 158 63 25.24 182 112 2.05 2.5 3.4 4.95 5.65 1.45 2.25 3.6 1.82 2.6 3.52 4.85 5.8 1.7 2.28 3.98
6 54 F 162 62 23.62 180 110 1.87 2.8 3 5 5 1.13 2.8 3.93 2.84 2.8 3 4.02 5.88 0.16 2.88 3.04
7 57 F 160 65 25.39 184 116 2.9 2.9 3.25 4.72 5.89 0.35 2.64 1.99 2.8 2.38 3 4.75 5.8 1.5 2.8 4
8 55 M 158 60 24.03 180 110 2.88 2.72 3.72 5.08 5.9 0.84 3.08 3.02 1.85 2.98 3.7 5.38 5.82 1.85 2.12 3.87
9 52 M 157 60 24.34 140 90 1.5 1.5 3.3 4 5.1 1.8 1.8 3.5 2.1 2.1 3 4.2 5.6 0.9 2.6 3.6
10 49 M 160 58 22.66 160 104 1.4 2.3 3.3 4 5.1 1.8 1.8 3.6 1.5 2.2 3.3 4.1 5.2 1.9 1.9 3.8
11 55 F 156 68 27.94 146 96 1.4 2.1 2.8 4.3 4.6 1.7 1.8 3.2 1.1 2 3 4.2 5 1.9 1.8 3.9
12 58 F 158 69 27.64 160 106 1 1.98 2.75 4 4.05 1.5 1.3 3.05 1.2 2.2 1.98 4 3.02 0.78 1.04 1.82
13 48 M 162 68 25.91 150 96 1.2 1.8 2.8 4.1 4.7 1.6 1.9 3.5 1.4 2.1 2.8 4.3 4.6 1.7 1.8 3.2
14 52 M 159 61 24.13 166 106 1.1 2 3 4.2 5 1.9 1.8 3.9 1.5 2.3 3.3 4 5.1 1.8 1.8 3.6
15 50 M 162 64 24.39 164 106 1.2 2 3 4 5 1.8 2 3.8 1.2 1.8 2.8 4.1 4.7 1.6 1.9 3.5
16 48 M 155 68 28.3 166 108 1 1.86 2.96 4.2 4.08 1.25 1.12 3.08 1.4 2.1 2.8 4.3 4.6 1.7 1.8 3.2
17 51 F 160 58 22.66 148 96 1 2 2.2 4.1 4.28 1.2 1.9 3.1 1.2 2.2 1.98 4 3.02 0.78 1.04 1.82
18 58 F 158 58 23.23 146 92 1.2 1.8 2.8 4.1 4.7 1.6 1.9 3.5 1 2 2.2 4.1 4.28 1.2 1.9 3.1
19 42 F 158 62 24.84 164 106 1.02 1.62 2.25 3.7 4.2 1.23 1.95 3.18 1.2 1.8 2.8 4.1 4.7 1.6 1.9 3.5
20 59 M 160 68 26.56 160 102 1 2 2.2 4.1 4.28 1.2 1.9 3.1 1.2 2.2 1.98 4 3.02 0.78 1.04 1.82
21 45 M 162 63 24.01 148 98 1.02 1.25 2.02 3 3.2 1 1.18 2.18 1.4 2.1 2.8 4.3 4.6 1.7 1.8 2.2
22 52 F 165 65 23.88 162 104 1.4 1.75 2.2 2.84 3.75 0.8 1.55 2.35 1.02 1.25 2.02 3 3.2 1 1.18 2.18
23 55 M 162 65 24.77 140 92 1.3 1.7 2 2.75 3 0.7 1 1.7 1.02 1.25 2.02 3 3.2 1 1.18 2.18
100
24 48 M 158 58 23.23 166 108 1.02 1.25 2.02 3 3.2 1 1.18 2.18 1.3 1.7 2 2.75 3 0.7 1 1.7
25 49 F 160 62 24.22 142 92 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7 1.4 2.3 2.25 2.85 3 0.85 0.75 1.6
26 58 M 162 64 24.39 160 100 1.3 2.2 2.8 3.5 4 1.5 1.2 2.7 1.4 2.3 2.25 2.85 3 0.85 0.75 1.6
27 48 F 152 59 25.54 142 92 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7
28 46 M 165 62 22.77 146 92 1.4 2.3 2.25 2.85 3 0.85 0.75 1.6 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73
29 58 M 160 60 23.44 162 104 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7 1.02 1.25 2.02 3 3.2 1 1.18 2.18
30 60 M 162 58 22.1 146 92 1.3 1.7 2 2.75 3 0.7 1 1.7 1.02 1.25 2.02 3 3.2 1 1.18 2.18
31 48 M 159 60 23.73 166 108 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73
32 58 F 160 62 24.22 146 92 1.02 1.25 2.02 3 3.2 1 1.18 2.18 1.3 1.1 2 2.75 3 0.7 1 1.7
33 60 M 158 62 24.84 148 92 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7 1.3 1.1 2 2.75 3 0.7 1 1.7
34 45 F 156 60 24.65 160 100 2.3 2.3 3.3 4 5.1 1.8 1.8 3.6 1.4 2.2 3.3 4.1 5.2 1.9 1.9 3.8
35 55 F 160 62 24.22 162 102 1.4 2.3 2.25 2.85 3 0.85 0.75 1.6 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73
36 40 F 158 64 25.64 140 90 1.25 1.75 2 2.75 3 0.75 1 1.75 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73
37 59 M 155 60 24.97 162 102 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7 1.02 1.25 2.02 3 3.2 1 1.18 2.18
38 48 F 160 62 24.22 146 92 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7
39 55 M 162 65 24.77 162 100 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73 1.4 2.3 2.25 2.85 3 0.85 0.75 1.6
40 45 F 158 60 24.03 146 92 1.02 1.25 2.02 3 3.2 1 1.18 2.18 1.02 1.72 2 2 2.25 0.98 0.98 1.73
41 #DIV/0!
42 42 F 158 59 23.63 118 86 1 1.25 1.75 3.2 3.75 0.75 2 2.75 1.2 1.35 1.85 2.75 3.2 0.65 1.35 2
43 48 F 156 60 24.65 128 88 1.3 1.85 2 2.35 2.65 0.7 0.65 1.35 1 1.25 1.75 3.2 3.75 0.75 2 2.75
44 52 M 160 60 23.44 130 86 1.4 1.75 2 2.25 3 0.6 1 1.6 1.25 1.48 2.25 2.5 2.75 1 0.5 1.5
45 55 M 159 62 24.52 120 82 1.2 1.35 1.85 2.75 3.2 0.65 1.35 2 1.3 1.85 2 2.35 2.65 0.7 0.65 1.35
46 48 M 162 58 22.1 128 86 1.45 1.85 2 2.25 2.65 0.55 0.65 1.2 1.65 1.25 1.75 2.25 2.35 0.1 0.6 0.7
47 52 M 165 60 22.04 130 84 1.25 1.45 1.75 2 2.45 0.5 0.7 1.2 1.45 1.85 2 2.25 2.25 0.55 0.65 1.2
48 56 M 160 56 21.88 126 88 1.65 1.25 1.75 2.25 2.35 0.1 0.6 0.7 1.25 1.45 1.75 2 2.45 0.5 0.7 1.2
49 45 F 150 58 25.78 110 70 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73 1.4 2.3 2.25 2.85 3 0.85 0.75 1.6
101
50 56 F 155 60 24.97 112 70 1.4 2.3 2.25 2.85 3 0.85 0.75 1.6 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73
51 50 M 159 61 24.13 120 84 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73 1.02 1.25 2.02 3 3.2 1 1.18 2.18
52 58 F 158 58 23.23 118 82 1 2 2.2 4.1 4.28 1.2 1.9 3.1 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73
53 55 M 160 59 23.05 120 88 1 2 2.2 4.1 4.28 0.5 1.9 3.1 1.02 1.72 2 2.25 2.75 0.1 0.75 1.73
54 52 M 158 58 23.23 126 82 1.25 1.45 1.75 2 2.45 1.2 0.7 1.2 1.65 1.25 1.75 2.25 2.35 0.98 0.6 0.7
55 55 M 156 60 24.65 130 88 1.02 1.25 2.02 3 3.2 0.5 0.7 1.2 1.3 2.2 2.45 2.75 3 2.35 0.6 0.7
56 54 M 154 56 23.61 120 80 1.02 1.25 2.02 3 3.2 0.5 0.7 1.2 1.3 2.2 2.45 2.75 3 2.35 0.6 1
57 45 F 152 55 23.81 110 86 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73
58 49 F 156 60 24.65 120 80 1.4 2.3 2.25 2.8 3 0.85 0.75 1.6 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7
59 51 F 160 59 23.05 122 88 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7 1.02 1.7 2 2.25 2.75 0.98 0.75 1.73
60 57 M 159 60 23.73 126 89 1.02 1.25 2.02 3 3.2 1 1.7 2.18 1.3 2.2 2.45 2.75 3 1.15 1.73 1.7
61 55 M 158 61 24.44 128 90 1 2 2.2 4.1 4.28 1.2 1.18 3.1 1.2 2.2 1.98 4 3.02 0.78 0.55 1.82
62 50 M 155 58 24.14 118 88 1.5 2.3 3.3 4 5.1 1.8 1.9 3.6 1.4 2.2 3.3 4.1 5.2 1.9 1.04 3.8
63 48 M 158 57 22.83 120 90 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73
64 50 F 156 62 25.48 126 90 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7 1.02 1.25 2.02 3 3.2 1 1.18 2.18
65 60 M 162 64 24.39 130 90 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7 1.4 2.3 2.25 2.85 3 0.8 0.75 1.6
66 56 F 159 60 23.73 130 90 1.3 1.7 2 2.75 3 0.7 1 1.7 1.02 1.25 2.02 3 3.2 1 1.18 2.18
67 47 F 158 60 24.03 126 80 1.02 1.25 2.02 3 3.2 1 1.18 2.18 1.3 1.7 2 2.75 3 0.7 1 1.7
68 50 M 160 62 24.22 128 88 1.4 2.1 2.8 4.3 4.6 1.7 1.8 2.2 1.02 1.25 2.02 3 3.2 1 1.18 2.18
69 45 F 158 60 24.03 128 88 1.2 1.8 2.8 4.1 4.7 1.6 1.9 3.5 1.02 1.62 2.25 3.7 4.2 1.23 1.95 3.18
70 42 F 148 55 25.11 110 70 1.2 2.2 1.98 4 3.02 0.78 1.04 1.82 1.02 2 2.2 4.1 4.28 1.2 1.9 3.1
71 52 M 160 62 24.22 120 90 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7 1.3 1.1 2 2.75 3 0.17 1 1.7
72 50 M 158 58 23.23 126 86 1.3 2.2 2.8 3.5 4 1.5 1.2 2.7 1.4 2.3 2.25 2.85 3 0.85 0.75 1.6
73 52 F 162 63 24.01 130 90 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73
74 58 F 162 58 22.1 130 80 1.4 2.3 2.25 2.85 3 0.85 0.75 1.6 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7
75 50 F 160 62 24.22 110 90 1.3 2.2 2.8 3.5 4 1.5 1.2 2.7 1.4 2.3 2.25 2.85 3 0.85 0.75 1.6
102
76 49 F 158 58 23.23 120 82 1.3 1.1 2 2.75 3 0.7 1 1.7 1.02 1.25 2.02 3 3.2 1 1.18 2.18
77 52 M 156 58 23.83 120 90 1.65 1.25 1.75 2.25 2.35 0.1 0.6 0.7 1.25 1.45 1.75 2 2.45 0.5 0.7 1.2
78 55 M 160 58 22.66 130 90 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73 1.4 2.3 2.25 2.85 3 0.85 0.75 1.6
79 60 M 158 60 24.03 128 90 1.3 2.2 2.45 2.75 3 1.15 0.55 1.7 1.02 1.25 2.02 3 3.2 1 1.18 2.18
80 57 M 159 59 23.34 120 86 1.25 1.75 2 2.75 3 0.75 1 1.75 1.02 1.72 2 2.25 2.75 0.98 0.75 1.73
